2017 Enmore Bio Conference

2017 Enmore Bio Conference (EBC 2017) is organized by Enmore Healthcare, with thousands of participants every year. EBC will focus on precision medicine, covering diagnosis, cure and pharmacy industry, meanwhile, integrating the relevant policy direction, market investment, development of techniques, and clinical application into those topics. EBC has provided an international crossover platform to promote the development of health industry for decision makers, promoting the innovation cooperation of healthcare industry.

8th World IVD Summit 2017, as the first high-level summit in China, was held successfully over the last decade. Outstanding representatives from research, industry and medical community will be invited to join in the event, delivering keynote speech, panel discussion and interview. The summit will focus on transformation of traditional enterprises and development of innovative enterprises in IVD industry, as well as the transformation of clinical application and the development of new techniques. Hope this time we can provide more creative ideas of the future development of IVD industry to all the attendees.

Antibody drug in the world and China has been concerned for many years from the generic to the new drug research. Not only large pharmaceutical companies in Europe and USA but also emerging markets in Asia flood into this area. Changes of policy and market have brought unprecedented opportunities and challenges to this field. However, at this stage, the antibody drug development, production, clinical and other aspects are still need to be improved. Policy guidance also will bring an unprecedented impact on the future of the industry.

Cellular immunotherapy, has bright prospect and infinite market share, making numerous scientists and investors pour into it. However, with some accidents in this treatment, many questions arise. However, every new technology, is always accompanied by controversy. These controversies bring us to calmly and deeply think about this industry, and difficulties. Policy guidance, the demand of market, technical breakthrough, these will accompany the cellular immunotherapy to better times.

We sincerely invite you to join in EBC 2017, looking forward to your attendance! And also thanks for your great support to Enmore Bio Conference.